Virus Detection by PCR, Lower Respiratory
Order Code:
LOPCR
Test Summary
Allows for rapid and highly sensitive detection and differentiation for infectious viral agents in primary clinical specimens as well as swab collections from primary sites on patient.
Aliases
- Virus Culture (Body Fluid or Tissue)
- Virus Isolation (Body Fluid or Tissue)
Specimen Collection
Special Instructions
N/A
Preferred Specimen
Acceptable specimen types and viruses tested are listed below:
Lower Respiratory Sources (i.e., Bronchial lavage or wash and tracheal aspirates)--viruses tested: Influenza A, Influenza B, RSV, Para 1,2,3, Adeno, Metapneumo, HSV, and CMV.
For any rare sources or questionable collection devices, please contact the Molecular department at: (937)297-8338
Minimum Volume
1.5 mL specimen in VTM
Instructions
Please specify specimen source. Urine does not require viral transport media. Transport in sterile container. Store refrigerated after collection
Patient Preparation
N/A
Storage
VTM (Viral Transport Medium)
UTM (Universal Transport Medium)
Sterile Container
UTM (Universal Transport Medium)
Sterile Container
Transport Temperature
Refrigerated
Specimen Stability
- Room Temperature = unacceptable
- Refrigerated = 5 days
- Frozen (VTM / Urine / CSF only)= 5 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
If specimen is left at room temperature notify Virology Department (937-297-3238) or write a comment on the requisition.
Order Code
LOPCR
EPIC (Premier) Code
LAB5570
Includes
N/A
CPT Code
- 87633
- 87798
- 87486
- 87581
- 87529 (2) 87496
Billing Code
- 306021
- 300767
- 306013
- 306032
- 300758
- 300751
CPT Statement
Methodology
This panel includes a mixture of Real Time PCRs and Real Time Reverse-Transcriptase PCRs (RT-PCR) for the amplification, detection, and differentiation of the following viruses: Enterovirus, CMV, HSV, VZV, Adenovirus, RSV, HMPV, Influenza A, Influenza B, Parainfluenza 1, 2, and 3. Multiple assays are involved--some of which are FDA approved and others that are not, but will include the CLIA non-FDA comment.
PLEASE NOTE; Extractions from primary specimens are included for some but not all testing in this panel, as the tests have had direct specimen use approval.
This test was developed and its performance characteristics determined by CompuNet Clinical Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be considered as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing.
PLEASE NOTE; Extractions from primary specimens are included for some but not all testing in this panel, as the tests have had direct specimen use approval.
This test was developed and its performance characteristics determined by CompuNet Clinical Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be considered as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing.
FDA Status
No - This test was developed, and its performance characteristics determined by CompuNet Clinical Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.
Physician Attestation of Informed Consent
N/A
Testing Laboratory
CompuNet Clinical Laboratories, LLC
2308 Sandridge Drive
Moraine OH, 45439
2308 Sandridge Drive
Moraine OH, 45439
Department
Molecular/Serology
Reference Range
N/A
Setup Schedule / Expected Turnaround Time
Sunday - Saturday; MD; Report available: 1 day
Specimen Collection
Special Instructions
N/A
Preferred Specimen
Acceptable specimen types and viruses tested are listed below:
Lower Respiratory Sources (i.e., Bronchial lavage or wash and tracheal aspirates)--viruses tested: Influenza A, Influenza B, RSV, Para 1,2,3, Adeno, Metapneumo, HSV, and CMV.
For any rare sources or questionable collection devices, please contact the Molecular department at: (937)297-8338
Minimum Volume
1.5 mL specimen in VTM
Instructions
Please specify specimen source. Urine does not require viral transport media. Transport in sterile container. Store refrigerated after collection
Patient Preparation
N/A
Storage
VTM (Viral Transport Medium)
UTM (Universal Transport Medium)
Sterile Container
UTM (Universal Transport Medium)
Sterile Container
Transport Temperature
Refrigerated
Specimen Stability
- Room Temperature = unacceptable
- Refrigerated = 5 days
- Frozen (VTM / Urine / CSF only)= 5 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
If specimen is left at room temperature notify Virology Department (937-297-3238) or write a comment on the requisition.
Billing
CPT Code
- 87633
- 87798
- 87486
- 87581
- 87529 (2) 87496
Billing Code
- 306021
- 300767
- 306013
- 306032
- 300758
- 300751
CPT Statement
Result Information
Methodology
This panel includes a mixture of Real Time PCRs and Real Time Reverse-Transcriptase PCRs (RT-PCR) for the amplification, detection, and differentiation of the following viruses: Enterovirus, CMV, HSV, VZV, Adenovirus, RSV, HMPV, Influenza A, Influenza B, Parainfluenza 1, 2, and 3. Multiple assays are involved--some of which are FDA approved and others that are not, but will include the CLIA non-FDA comment.
PLEASE NOTE; Extractions from primary specimens are included for some but not all testing in this panel, as the tests have had direct specimen use approval.
This test was developed and its performance characteristics determined by CompuNet Clinical Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be considered as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing.
PLEASE NOTE; Extractions from primary specimens are included for some but not all testing in this panel, as the tests have had direct specimen use approval.
This test was developed and its performance characteristics determined by CompuNet Clinical Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be considered as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing.
Testing Laboratory
N/A
Reference Range
N/A
Setup Schedule / Expected Turnaround Time
Sunday - Saturday; MD; Report available: 1 day